Novo Nordisk Invest 4 A/S
CVR 31853923 · Public limited company (A/S) · Active · Low risk
Novo Nordisk Invest 4 A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 18 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.8m and a net result of DKK -23k. CEO: Anders Rytter Mikkelsen.
Bankruptcy risk for Novo Nordisk Invest 4 A/S
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 31853923
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (17 years)
- Address
- c/o Novo Nordisk A/S, Novo Alle 1
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 1.0m
- Employees
- 0 (2017)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 18 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 96.4% |
| Current ratio | 2,745% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 13 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -64k | DKK -55k | DKK -53k |
| Net profit | DKK -23k | DKK 7,000 | DKK 5,000 |
| Equity | DKK 1.8m | DKK 1.8m | DKK 1.8m |
| Total assets | DKK 1.8m | DKK 1.8m | DKK 1.8m |
| Short-term debt | DKK 67k | DKK 50k | – |
| Tax owed | DKK 0 | DKK 2,000 | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · DeloitteStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 159 | ||
| 1 Jan 2024 – 31 Dec 2024 | 153 | ||
| 1 Jan 2023 – 31 Dec 2023 | 156 | ||
| 1 Jan 2022 – 31 Dec 2022 | 145 | ||
| 1 Jan 2021 – 31 Dec 2021 | 140 | ||
| 1 Jan 2020 – 31 Dec 2020 | 147 | ||
| 1 Jan 2019 – 31 Dec 2019 | 150 | ||
| 1 Jan 2018 – 31 Dec 2018 | 147 | ||
| 1 Jan 2017 – 31 Dec 2017 | 136 | ||
| 1 Jan 2016 – 31 Dec 2016 | 129 | ||
| 1 Jan 2015 – 31 Dec 2015 | 123 | ||
| 1 Jan 2014 – 31 Dec 2014 | 142 | ||
| 1 Jan 2013 – 31 Dec 2013 | 90 | ||
| 1 Jan 2012 – 31 Dec 2012 | 97 | ||
| 1 Jan 2011 – 31 Dec 2011 | 106 | ||
| 1 Jan 2010 – 31 Dec 2010 | 87 | ||
| 1 Jan 2009 – 31 Dec 2009 | 82 | ||
| 17 Nov 2008 – 31 Dec 2008 | 112 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Anders Rytter Mikkelsen | Current | |
| CEO | Knut Borch-Johnsen | ||
| CEO | John James Nolan | ||
| CEO | Karsten Munk Knudsen | ||
| CEO | Peter Bøggild | ||
| Board | Linette Tangsgaard Nielsen | Current | |
| Board | Naja Eilers Barrisøe | Current | |
| Board | Thomas Rask Nielsen | Current | |
| Board | Ole Falvig Ramsby | ||
| Board | Lars Rebien Sørensen | ||
| Board | Gert Almind Frederiksen | ||
| Board | Niels Borregaard | ||
| Board | Lise Kingo | ||
| Board | Peter Jens Lindholm Kurtzhals | ||
| Board | Martinus Hermanus Soeters | ||
| Board | Allan Arthur Vaag | ||
| Board | Anne Birgitte Urup Hemmingsen | ||
| Board | Dorthe Tecza | ||
| Board | Peder Rasmussen | ||
| Board | Charlotte Brøns | ||
| Board | Kirsten Engelhard Nielsen | ||
| Board | Dorthe Tecza | ||
| Board | Birgitte Nauntofte | ||
| Board | Alan Charles Moses | ||
| Board | Søren Thor Jensen | ||
| Board | Nana Folmann Hempler | ||
| Board | Majken Borup Linnemann Jensen | ||
| Board | Kristine Færch | ||
| Board | Bo Ahrén | ||
| Board | Lars Rebien Sørensen | ||
| Board | Mads Krogsgaard Thomsen | ||
| Board | Ole Falvig Ramsby | ||
| Board | Jesper Brandgaard | ||
| Board | Lars Fruergaard Jørgensen | ||
| Board | Lene Moth Bang | ||
| Board | Karsten Munk Knudsen | ||
| Board | Tomas Haagen | ||
| Board | Kristine Aachmann Bethe | ||
| Board | John Francis Kuckelman | ||
| Owner (100%) | NOVO NORDISK A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | NOVO NORDISK A/S | Current |
The CEOs' other companies
Anders Rytter Mikkelsen – 9 other companies
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk Denmark A/S Active
- Novo Nordisk North America Operations A/S Active
Karsten Munk Knudsen – 14 other companies
- 3SHAPE HOLDING A/S Active
- HEMPEL A/S Active
- NNE A/S Active
- NOVO NORDISK A/S Active
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMA OPERATIONS A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk Denmark A/S Active
- Novo Nordisk North America Operations A/S Active
Peter Bøggild – 12 other companies
- Anpartsselskabet af 21.08.2026 Opløst
- NNIT A/S Active
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk North America Operations A/S Active
- PBGG Holding ApS Active
- TRIO INVEST ApS Opløst
Address history (1 moves)
| c/o Novo Nordisk A/S, Novo Alle 1, 2880 Bagsværd | |
| Niels Steensens Vej 2, 2820 Gentofte |
Former names
| Novo Nordisk Invest 4 A/S | – now |
| STENO DIABETES CENTER A/S | – |
Employees per year
Other companies at the same address
- NOVO NORDISK A/S Active
- NOVO NORDISK FARMAKA DANMARK A/S Opløst
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 1 A/S Opløst
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMA OPERATIONS A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- NOVO NORDISK SECURITY A/S Opløst
- Novo Nordisk North America Operations A/S Active
Similar companies in Gladsaxe
- JOHANSEN OG HEIDEN FINANS ApS Bagsværd
- JEBRAKA ApS Bagsværd
- OLIVER ANDERSEN HOLDING A/S Bagsværd
- CORE HOLDING ApS Søborg
- Viking Holdings ApS Søborg
- Kriterion Holding ApS Søborg
- JogS Holding ApS Kongens Lyngby
- Nordkvist Holding ApS Søborg
- Duchan Holding ApS Søborg
- Leafshore Holding ApS Søborg
- Holdingselskabet Andersen & Meldgaard ApS Søborg
- A&H Holding ApS Søborg
Questions and answers about Novo Nordisk Invest 4 A/S
Has Novo Nordisk Invest 4 A/S gone bankrupt?
No, Novo Nordisk Invest 4 A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Novo Nordisk Invest 4 A/S?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Novo Nordisk Invest 4 A/S?
Anders Rytter Mikkelsen is the CEO of Novo Nordisk Invest 4 A/S.
Who is the auditor of Novo Nordisk Invest 4 A/S?
Novo Nordisk Invest 4 A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Novo Nordisk Invest 4 A/S founded?
Novo Nordisk Invest 4 A/S was founded on 17 November 2008.
What is the equity of Novo Nordisk Invest 4 A/S?
Equity was DKK 1.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.